MRD / Regn No. : SG004505 Date : 02/06/2026
Patient Name : Vijiya Pareek Age & Gender : 65 Yrs. / Female
Contact No. : 9831733444 UHID :
Ht / Wt / BMI : / 85 / BP S / BP D : 158 / 86
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (02/Jun/2018) | DYSLIPIDEMIA (02/Jun/2026) |
Salient Investigations : CREATININE: 0.66 | EGFR EGLOMERULAR FILTRATION RATE: 96.29 mL/min/1.73m2 | HB HEMOGLOBIN: 13.5 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 14.4 % | LDL LOW DENSITY LIPOPROTEIN: 146 mg/dL | MICROALBUMIN CREATININE RATIO: 182.95 mcg/mg | TSH THYROID STIMULATING HORMONE: 8.146 mIU/L
S# Generic (Trade) Name Route Dosage Usage Duration
1 GLICLAZIDE 80 MG + METFORMIN 500 MG
GLIZID M 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG
APDA 10 MG 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 INJECTION SEMAGLUTIDE 0.25 MG
NOVELTREAT 0.25 		SC ONCE A WEEK AFTER BREAKFAST
 TILL NEXT VISIT
4 TABLET ROSUVASTATIN 20 MG
STATEZE R 20 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 02/Oct/2026
Tests Suggested For Next Visit : CHECK FASTING AND PP AFTER 4 WEEKS AND INFORM,HBA1C-HPLC METHOD,RETINA CHECK UP,CREATININE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: